Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayvon Modjarrad

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
Plos Pathogens|June 25, 2021
Impact of prior Dengue immunity on Zika vaccine protection in rhesus macaques and miceRafael A Larocca, Peter Abbink, John D Ventura, et al.
Frontiers in Immunology|March 15, 2021
Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated VaccineNoemia S Lima, Damee Moon, Samuel Darko, et al.
Viruses|March 6, 2019
Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and AlpacasDanielle R Adney, Lingshu Wang, Neeltje van Doremalen, et al.
Plos One|December 28, 2023
Risk of sexually transmitted infections among U.S. military service members in the setting of HIV pre-exposure prophylaxis useJason M Blaylock, Evan C Ewers, Elizabeth J Bianchi, et al.
Plos One|June 3, 2021
Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platformSidhartha Chaudhury, Jack Hutter, Jessica S Bolton, et al.
Science (New York, N.Y.)|April 27, 2013
Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibodyJason S McLellan, Man Chen, Sherman Leung, et al.
Vaccine: X|August 7, 2019
rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessmentThomas P Monath, Patricia E Fast, Kayvon Modjarrad, et al.
Vaccines|April 27, 2026
A Study to Investigate the Safety and Immunogenicity of Monovalent Omicron LP.8.1-Adapted BNT162b2 COVID-19 Vaccine in Adults ≥ 65 Years of Age and High-Risk Adults 18-64 Years of Age (Preliminary Results)Rucha Dadhe, Juleen Gayed, Muneeb Iqbal, et al.
Journal of Public Health (Oxford, England)|May 3, 2023
Transmission of SARS-CoV-2 among recruits in a US Army training environment: a brief reportShilpa Hakre, Irina Maljkovic-Berry, Jun Hang, et al.
Nature Communications|December 1, 2017
Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoproteinDaiyin Tian, Michael B Battles, Syed M Moin, et al.
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Plos Pathogens|June 25, 2021
Impact of prior Dengue immunity on Zika vaccine protection in rhesus macaques and miceRafael A Larocca, Peter Abbink, John D Ventura, et al.
Frontiers in Immunology|March 15, 2021
Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated VaccineNoemia S Lima, Damee Moon, Samuel Darko, et al.
Viruses|March 6, 2019
Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and AlpacasDanielle R Adney, Lingshu Wang, Neeltje van Doremalen, et al.
Plos One|December 28, 2023
Risk of sexually transmitted infections among U.S. military service members in the setting of HIV pre-exposure prophylaxis useJason M Blaylock, Evan C Ewers, Elizabeth J Bianchi, et al.
Plos One|June 3, 2021
Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platformSidhartha Chaudhury, Jack Hutter, Jessica S Bolton, et al.
Science (New York, N.Y.)|April 27, 2013
Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibodyJason S McLellan, Man Chen, Sherman Leung, et al.
Vaccine: X|August 7, 2019
rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessmentThomas P Monath, Patricia E Fast, Kayvon Modjarrad, et al.
Vaccines|April 27, 2026
A Study to Investigate the Safety and Immunogenicity of Monovalent Omicron LP.8.1-Adapted BNT162b2 COVID-19 Vaccine in Adults ≥ 65 Years of Age and High-Risk Adults 18-64 Years of Age (Preliminary Results)Rucha Dadhe, Juleen Gayed, Muneeb Iqbal, et al.
Journal of Public Health (Oxford, England)|May 3, 2023
Transmission of SARS-CoV-2 among recruits in a US Army training environment: a brief reportShilpa Hakre, Irina Maljkovic-Berry, Jun Hang, et al.
Nature Communications|December 1, 2017
Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoproteinDaiyin Tian, Michael B Battles, Syed M Moin, et al.
Pageof 14